US$0.98 (vs US$1.16 in 2Q 2023)
Utah Medical Products (NASDAQ:UTMD) Second Quarter 2024 ResultsKey Financial ResultsRevenue: US$10.4m (down 19% from 2Q 2023).Net income: US$3.45m (down 18%...
Utah Medical Products (NASDAQ:UTMD) Second Quarter 2024 ResultsKey Financial ResultsRevenue: US$10.4m (down 19% from 2Q 2023).Net income: US$3.45m (down 18%...